US equities
|
INTC
$119.13
▼-0.17%
MU
$1,074.89
▲+0.00%
NVDA
$233.95
▲+0.00%
SNDK
$1,719.99
▲+0.00%
SPCX
$158.96
▲+0.00%
SDEV
$7.48
▲+0.00%
TSLA
$370.59
▲+0.00%
AMD
$633.91
▲+0.00%
INTC
$119.13
▼-0.17%
MU
$1,074.89
▲+0.00%
NVDA
$233.95
▲+0.00%
SNDK
$1,719.99
▲+0.00%
SPCX
$158.96
▲+0.00%
SDEV
$7.48
▲+0.00%
TSLA
$370.59
▲+0.00%
AMD
$633.91
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Beta Bionics, Inc. - Common Stock
(NQ:
BBNX
)
18.96
UNCHANGED
Delayed Quote
Updated: 4:00 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Beta Bionics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Beta Bionics, Inc. of Class Action Lawsuit and Upcoming Deadlines – BBNX
September 22, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Beta Bionics, Inc. Notice of November 3, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
September 22, 2026
From
Kahn Swick & Foti, LLC
Via
GlobeNewswire
BETA BIONICS, INC. (BBNX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Beta Bionics, Inc. Investors of Upcoming Deadline
September 22, 2026
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Kaplan Fox Urges Beta Bionics, Inc. (NASDAQ: BBNX) Investors to Contact the Firm Before the Deadline on November 3, 2026
September 22, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit
September 22, 2026
From
Schall, Brown & Schwartz LLP
Via
GlobeNewswire
Important Notice to Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Beta Bionics, Inc. (NASDAQ: BBNX); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and The Simply Good Foods Company (NASDAQ: SMPL): Grabar Law Office is
September 22, 2026
From
Grabar Law Office
Via
GlobeNewswire
Beta Bionics Announces Agreement Integrate the iLet® Bionic Pancreas and mint™ with Senseonics’ Eversense® 365
September 22, 2026
From
Beta Bionics, Inc.
Via
GlobeNewswire
Kaplan Fox Announces a Securities Class Action Filed Against Beta Bionics, Inc. (NASDAQ: BBNX) - Lead Plaintiff Deadline is November 3, 2026
September 21, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Kaplan Fox Notifies Beta Bionics, Inc. (NASDAQ: BBNX) Investors of a Securities Class Action Deadline on November 3, 2026
September 21, 2026
From
Kaplan Fox & Kilsheimer, LLP
Via
GlobeNewswire
Kaplan Fox Continues to Remind Beta Bionics, Inc. (NASDAQ: BBNX) Investors of the Lead Plaintiff Deadline on November 3, 2026
September 18, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Robbins LLP Urges BBNX Stockholders Who Lost Money Investing in Beta Bionics, Inc. to Contact the Firm for Information About Leading the Class Action
September 18, 2026
From
Robbins LLP
Via
Business Wire
Kaplan Fox Urges Investors of Beta Bionics, Inc. (NASDAQ: BBNX) with Significant Losses to Seek a Leadership Role Before November 3, 2026
September 18, 2026
From
Kaplan Fox & Kilsheimer, LLP
Via
GlobeNewswire
Kaplan Fox Continues to Alert Investors of a Securities Class Action Deadline on November 3, 2026 Against Beta Bionics, Inc. (NASDAQ: BBNX)
September 17, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Beta Bionics Announces Closing of $172.5 Million Public Offering of Common Stock
September 17, 2026
From
Beta Bionics, Inc.
Via
GlobeNewswire
Beta Bionics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Beta Bionics, Inc. - BBNX
September 17, 2026
From
SkyMedia, LLC
Via
GlobeNewswire
Kaplan Fox Continues to Alert Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to a Class Action Deadline on November 3, 2026
September 17, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Beta Bionics, Inc. (BBNX)
September 17, 2026
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Kaplan Fox Encourages Beta Bionics, Inc. (NASDAQ: BBNX) Investors Seeking Recovery to Contact the Firm Before November 3, 2026
September 16, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
BETA BIONICS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Beta Bionics, Inc. and Encourages Investors to Contact the Firm
September 16, 2026
From
Bragar Eagel & Squire
Via
GlobeNewswire
Kaplan Fox Reminds Beta Bionics, Inc. (NASDAQ: BBNX) Investors Seeking Recovery of the Lead Plaintiff Deadline on November 3, 2026
September 16, 2026
From
Kaplan Fox & Kilsheimer, LLP
Via
GlobeNewswire
Important Notice to Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Beta Bionics, Inc. (NASDAQ: BBNX); Erasca, Inc. (NASDAQ: ERAS); and Hub Group, Inc. (NASDAQ: HUBG): Grabar Law Office is Investigating Claims on Your Behalf
September 16, 2026
From
Grabar Law Office
Via
GlobeNewswire
Beta Bionics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
September 15, 2026
From
Beta Bionics, Inc.
Via
GlobeNewswire
Beta Bionics, Inc. Notice of November 3, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
September 15, 2026
From
Kahn Swick & Foti, LLC
Via
GlobeNewswire
Beta Bionics Announces Proposed Public Offering of $125.0 Million of Common Stock
September 15, 2026
From
Beta Bionics, Inc.
Via
GlobeNewswire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BBNX
September 15, 2026
From
The Rosen Law Firm PA
Via
GlobeNewswire
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit
September 15, 2026
From
Schall, Brown & Schwartz LLP
Via
GlobeNewswire
BETA BIONICS, INC. INVESTORS WITH LOSSES HAVE UNTIL NOVEMBER 3, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline
September 15, 2026
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Did You Lose Money Investing in Beta Bionics, Inc.? Robbins LLP Urges Investors with Significant Losses to Contact the Firm for Information About Their Rights Against BBNX
September 14, 2026
San Diego, California--(Newsfile Corp. - September 14, 2026) - Shareholder rights law firm Robbins LLP reminds investors that a class...
Via
Newsfile
Topics
Lawsuit
Beta Bionics Announces FDA Clearance of Mint™, the Company’s Transformative Patch Pump, and Unveils 3D Intelligence™ as its Next-Generation Insulin Dosing Algorithm
September 14, 2026
From
Beta Bionics, Inc.
Via
GlobeNewswire
Senseonics Announces Strategic Partnership with Beta Bionics to Integrate Eversense® 365 with the iLet® Bionic Pancreas
September 14, 2026
From
Senseonics Holdings, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
Next >
